Brian Ball, MD, MS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    MDS
    Date added:
    03/19/2024
    Date updated:
    03/27/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Rigel
    Topic:
    AML
    Date added:
    03/19/2024
    Date updated:
    03/27/2025
    Relationship end date:
    12/15/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Sanofi
    Topic:
    Advisory Board
    Date added:
    03/27/2025
    Date updated:
    03/27/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Syndax Pharmaceuticals
    Topic:
    Advisory Board & Reseacrh Support
    Date added:
    03/27/2025
    Date updated:
    03/27/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    Advisory Board
    Date added:
    03/27/2025
    Date updated:
    03/27/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Genentech
    Topic:
    Research Support
    Date added:
    03/27/2025
    Date updated:
    03/27/2025
Return to Las Vegas Hematologic Malignancies Symposium